altimmune glp-1 ($ALT): Best-in-Class Tolerability, One Real Fibrosis Question, and a Serious-Liver-Disease Franchise the Market Is Pricing at Almost Nothing Altimmune's Glucagon/GLP-1 Dual Receptor Agonist

There is evidence of androgen excess, altered glucocorticoid regulation and changes in pro-inflammatory cytokines

Explore the mechanisms, clinical applications, and future opportunities of GLP-1 receptor agonists in drug development and disease management.

Members of myHSteam consistently seek ways to feel better

Learn how they work, who theyre for, and why theyre making headlines.

Clinical Evidence for GLP-1 Receptor Agonists in Alzheimers Disease. PubMed Cheng HW et al

The rate of metabolic bariatric surgery decreased from 2022 to 2023, whereas the use of GLP-1 receptor agonists as anti-obesity medications grew over twofold, a research letter showed